Deep Learning-based Synthesis of Amyloid PET Images from Structural MRI in Alzheimer's Disease.

IF 2.5 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Zongpai Zhang, Jingpu Wu, Puyang Wang, Keyi Chai, Shanshan Jiang, Chiadi U Onyike, Gwenn S Smith, Jinyuan Zhou
{"title":"Deep Learning-based Synthesis of Amyloid PET Images from Structural MRI in Alzheimer's Disease.","authors":"Zongpai Zhang, Jingpu Wu, Puyang Wang, Keyi Chai, Shanshan Jiang, Chiadi U Onyike, Gwenn S Smith, Jinyuan Zhou","doi":"10.1007/s11307-026-02145-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Amyloid-beta (Aβ) plaques in Alzheimer's disease (AD) are commonly imaged with specific PET radiotracers. To overcome the cost and availability limitations of PET, developing a more accessible diagnostic tool is essential. This study aimed to develop a deep-learning model that can synthesize Aβ-PET images from widely available MRI scans.</p><p><strong>Methods: </strong>The study utilized 431 subjects with both structural MRI and Aβ-PET scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, including 213 cognitively normal (CN), 180 mild cognitive impairment (MCI), and 38 AD dementia cases. A specialized Vector Quantized Generative Adversarial Network (VQGAN) framework has been trained to generate Aβ-PET images from MRI features, utilizing datasets from patients across various stages of AD spectrum. A paired t-test was used to compare synthetic and real Aβ-PET scans, while an ANOVA was performed to evaluate standardized uptake value ratio differences among the CN, MCI, and AD dementia groups.</p><p><strong>Results: </strong>The synthesized Aβ-PET images closely resemble real Aβ-PET scans in terms of regional Aβ distribution, accurately capturing disease-stage characteristics across the AD spectrum. In three key cortical brain regions (frontal cortex, lateral temporal lobe, and posterior cingulate cortex and precuneus), the synthetic images have successfully replicated disease-related Aβ trends, showing statistically significant group differences (p < 0.05). Quantitative evaluation has confirmed the superiority of VQGAN over other models (lower MAE, higher PSNR/SSIM), demonstrating minimized errors, reduced noise, and better structural fidelity in synthesized images.</p><p><strong>Conclusion: </strong>This technology potentially offers a cost-effective, non-invasive alternative method for AD diagnosis and staging.</p>","PeriodicalId":18760,"journal":{"name":"Molecular Imaging and Biology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Imaging and Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11307-026-02145-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale: Amyloid-beta (Aβ) plaques in Alzheimer's disease (AD) are commonly imaged with specific PET radiotracers. To overcome the cost and availability limitations of PET, developing a more accessible diagnostic tool is essential. This study aimed to develop a deep-learning model that can synthesize Aβ-PET images from widely available MRI scans.

Methods: The study utilized 431 subjects with both structural MRI and Aβ-PET scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, including 213 cognitively normal (CN), 180 mild cognitive impairment (MCI), and 38 AD dementia cases. A specialized Vector Quantized Generative Adversarial Network (VQGAN) framework has been trained to generate Aβ-PET images from MRI features, utilizing datasets from patients across various stages of AD spectrum. A paired t-test was used to compare synthetic and real Aβ-PET scans, while an ANOVA was performed to evaluate standardized uptake value ratio differences among the CN, MCI, and AD dementia groups.

Results: The synthesized Aβ-PET images closely resemble real Aβ-PET scans in terms of regional Aβ distribution, accurately capturing disease-stage characteristics across the AD spectrum. In three key cortical brain regions (frontal cortex, lateral temporal lobe, and posterior cingulate cortex and precuneus), the synthetic images have successfully replicated disease-related Aβ trends, showing statistically significant group differences (p < 0.05). Quantitative evaluation has confirmed the superiority of VQGAN over other models (lower MAE, higher PSNR/SSIM), demonstrating minimized errors, reduced noise, and better structural fidelity in synthesized images.

Conclusion: This technology potentially offers a cost-effective, non-invasive alternative method for AD diagnosis and staging.

基于深度学习的阿尔茨海默病结构MRI淀粉样蛋白PET图像合成
原理:阿尔茨海默病(AD)的淀粉样蛋白- β (Aβ)斑块通常用特异性PET示踪剂成像。为了克服PET的成本和可用性限制,开发一种更容易获得的诊断工具至关重要。本研究旨在开发一种深度学习模型,该模型可以从广泛可用的MRI扫描中合成a β- pet图像。方法:该研究使用了来自阿尔茨海默病神经成像计划(ADNI)数据库的431例患者的结构MRI和Aβ-PET扫描,其中包括213例认知正常(CN), 180例轻度认知障碍(MCI)和38例AD痴呆病例。一个专门的矢量量化生成对抗网络(VQGAN)框架已经被训练用来从MRI特征中生成Aβ- pet图像,利用来自AD谱不同阶段患者的数据集。配对t检验用于比较合成和真实的Aβ- pet扫描,而方差分析用于评估CN, MCI和AD痴呆组之间的标准化摄取值比差异。结果:合成的Aβ- pet图像在Aβ的区域分布方面与真实的Aβ- pet扫描非常相似,准确地捕捉了AD频谱的疾病分期特征。在三个关键的大脑皮层区域(额叶、外侧颞叶、后扣带皮层和楔前叶),合成图像成功地复制了与疾病相关的a β趋势,显示出统计学上显著的组差异(p结论:该技术可能为阿尔茨海默病的诊断和分期提供了一种经济、无创的替代方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
3.20%
发文量
95
审稿时长
3 months
期刊介绍: Molecular Imaging and Biology (MIB) invites original contributions (research articles, review articles, commentaries, etc.) on the utilization of molecular imaging (i.e., nuclear imaging, optical imaging, autoradiography and pathology, MRI, MPI, ultrasound imaging, radiomics/genomics etc.) to investigate questions related to biology and health. The objective of MIB is to provide a forum to the discovery of molecular mechanisms of disease through the use of imaging techniques. We aim to investigate the biological nature of disease in patients and establish new molecular imaging diagnostic and therapy procedures. Some areas that are covered are: Preclinical and clinical imaging of macromolecular targets (e.g., genes, receptors, enzymes) involved in significant biological processes. The design, characterization, and study of new molecular imaging probes and contrast agents for the functional interrogation of macromolecular targets. Development and evaluation of imaging systems including instrumentation, image reconstruction algorithms, image analysis, and display. Development of molecular assay approaches leading to quantification of the biological information obtained in molecular imaging. Study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics. Extension of in vitro and in vivo discoveries using disease models, into well designed clinical research investigations. Clinical molecular imaging involving clinical investigations, clinical trials and medical management or cost-effectiveness studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书